Lv6
2140 积分 2023-05-13 加入
Maneuver Conditioned Vehicle Trajectory Prediction Using Self-Attention
1年前
已关闭
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer
1年前
已完结
Tumour burden and efficacy of immune-checkpoint inhibitors
2年前
已完结
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer
2年前
已完结
Circulating tumor DNA and liquid biopsy in oncology
2年前
已完结
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
2年前
已完结
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment
2年前
已完结
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment
2年前
已关闭
The Cross-Entropy Method for Optimization
2年前
已完结
Perioperative ctDNA-based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)
2年前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
7个月前
已采纳
A durable superwetting clusters-inlayed mesh with high efficiency and flux for emulsion separation
1年前
已采纳
Source characteristics of polycyclic aromatic hydrocarbons and polychlorinated biphenyls in surface soils of Shenyang, China: A comparison of two receptor models combined with Monte Carlo simulation
1年前
已采纳
Analyzing Longitudinal Growth Data in Orthodontics
1年前
已采纳
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial
1年前
已采纳
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
1年前
已采纳
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
1年前
已采纳
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
1年前
已采纳
SceneNet: A Multi-Feature Joint Embedding Network With Complexity Assessment for Power Line Scene Classification
1年前
已采纳
皖公网安备34019202002308
